Bleomycin therapy for head and neck cancer can cause lung side effects in 24% of patients, with peaks at 1 and 4-6 weeks. Pre-existing emphysema increases the risk of lung complications.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: